Capital Fund Management S.A. Chemo Centryx, Inc. Call Options Transaction History

Capital Fund Management S.A.

$36 Billion
Q3 2024

Call Options

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2022 May 12, 2022	SELL	$22.22 - $39.12 $1.45 Million - $2.55 Million	-65,200 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$18.38 - $40.5 $880,402 - $1.94 Million	47,900 Added 276.88%	65,200 $2.37 Million
Q3 2021 Nov 12, 2021	BUY	$13.18 - $19.83 $228,014 - $343,058	17,300 New	17,300 $295,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.